SCHEMBL2273168

SCHEMBL2273168

O=C(Nc1cc(-n2cccc2)ccc1C(=O)O)c1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SERPINE1 P05121 3/20 0.61
PKM P14618 3/20 0.60
KMT2A Q03164 3/20 0.60
MEN1 O00255 2/20 0.60
GRIK1 P39086 2/20 0.60
MAPT P10636 1/20 0.60
TDP1 Q9NUW8 1/20 0.60
KDM4E B2RXH2 1/20 0.55
ALDH1A1 P00352 1/20 0.55
POLB P06746 1/20 0.55
HPGD P15428 1/20 0.55
MAPK1 P28482 1/20 0.55
HSD17B10 Q99714 1/20 0.55
KDM4D Q6B0I6 1/20 0.50
KDM4C Q9H3R0 1/20 0.50
SIRT6 Q8N6T7 1/20 0.49
LTC4S Q16873 1/20 0.49
DHODH Q02127 1/20 0.49
CA12 O43570 2/20 0.48
CA7 P43166 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2272853 0.89 ACLY (0.60) SERPINE1PKMKMT2AMEN1GRIK1
SCHEMBL14429559 0.89 SERPINE1 (0.52) SERPINE1PKMKMT2AMEN1GRIK1
SCHEMBL2272006 0.85 ACLY (0.62) SERPINE1PKMKMT2AMEN1GRIK1
SCHEMBL2269037 0.83 ACLY (0.59) SERPINE1PKMKMT2AMEN1GRIK1
SCHEMBL2275558 0.82 SERPINE1 (0.58) SERPINE1PKMKMT2AMEN1GRIK1
SCHEMBL2273439 0.82 SERPINE1 (0.46) SERPINE1PKMKMT2AMEN1GRIK1
SCHEMBL27696869 0.81 ALDH1A1 (0.47) SERPINE1PKMKMT2AMEN1GRIK1
SCHEMBL2271446 0.81 PYGM (0.50) SERPINE1PKMKMT2AMEN1AOC2
SCHEMBL2274028 0.79 PKM (0.52) SERPINE1PKMKMT2AMEN1GRIK1
SCHEMBL2271365 0.77 PKM (0.70) SERPINE1PKMKMT2AMEN1GRIK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101094829-B novel anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO.,LTD. (JP) 2012-02-08 CN disclosed
US-7999132-B2 Anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2011-08-16 US disclosed
US-7999132-B2 Anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2011-08-16 US disclosed
US-7999132-B2 Anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2011-08-16 US disclosed
US-20090240052-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2009-09-24 US disclosed
US-20090240052-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2009-09-24 US disclosed
US-20090240052-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2009-09-24 US disclosed
CN-101094829-A Novel anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO LTD (JP) 2007-12-26 CN disclosed
EP-1820795-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2007-08-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090240052-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF MMP13, MMP26, MMP11 SERPINE1 101/4885PKM 2367/4885KMT2A 1669/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.